IMPC (IMAGERIE MEDICALE PARIS CENTRE) acquired by QUALIUM
Context
Qualium Investissement is acquiring a 25% minority stake in IMPC from its associate radiologists. This primary LBO transaction follows a strategic period of reflection during which the founding doctors chose to maintain operational and capital control of their group rather than pursuing a majority sale. The operation is designed to provide the necessary capital to fund a targeted external growth strategy, particularly in the Paris region, while offering a medical-led alternative to the broader consolidation of the imaging market. A significant portion of the deal structure involves doubling the number of associates to integrate a new generation of radiologists into the group's governance. The transaction is supported by a senior debt facility that includes a substantial capital expenditure line for future acquisitions aimed at reinforcing the group's medical specialties. This partnership emphasizes long-term independence and professional excellence in a rapidly evolving regulatory and financial environment for medical practices.
IMPC (IMAGERIE MEDICALE PARIS CENTRE), which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
IMPC is a premier Parisian medical imaging group specializing in high-end diagnostics and interventional radiology. The organization operates through a network of 10 sites, including both private clinics and integrated centers within hospitals. The group is widely recognized for its technical leadership in 3 core medical domains: musculoskeletal imaging, women's health, and interventional procedures. Its reputation for excellence in sports medicine has led to prestigious partnerships with professional sports clubs and national athletic federations, including those for tennis and football, to provide specialized monitoring for elite athletes. Managed by a team of associate radiologists, the group manages over one hundred thousand patients annually, combining advanced technological equipment with specialized medical expertise to maintain its position as a leading independent player in the French healthcare landscape.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in Healthcare & Pharma
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 11/2024 | GROUPE IMAGERIE CARDINET | RADIOLOGIE PARIS OUEST | FRANCE | Health Providers | Groupe Imagerie Cardinet acquired 100% of Radiologie Paris Ouest from its previous majority shareholder, Azulis Capital, which had held a stake since 2019. The transaction was financed with the support of Andera Acto (Andera Partners' sponsorless/mezzanine arm), which had already invested in Cardinet in 2023 |
| 11/2024 | WELLTOWER | CARE UK | UNITED KINGDOM | Health Providers | Bridgepoint divested its entire stake in Care UK to Welltower, a US healthcare REIT, marking the conclusion of approximately 14 years of private equity ownership. Bridgepoint had originally acquired Care UK in 2010 and had previously attempted an unsuccessful sale process, incurring £2 |
| 10/2024 | ARDIAN | VISTA VISION | ITALY | Health Providers | Ardian Expansion acquired a majority stake in Vista Vision from its founders and Credem Private Equity. The transaction marks a new strategic phase for the group, following a period of rapid expansion where revenues tripled under Credem's tenure |
| 10/2024 | MONTEFIORE INVESTMENT | DEMENEGO | ITALY | Health Providers | Montefiore Investment acquired a majority stake in Demenego from Vam Investments. This secondary LBO follows a highly successful four-year period of ownership by the seller, during which the company more than doubled its revenue and expanded its retail network from 15 to 39 stores |
| 08/2024 | ORLANDO HEALTH | BROOKWOOD BAPTIST HEALTH SERVICES | UNITED STATES | Health Providers | Orlando Health signed a definitive agreement to acquire Tenet Healthcare's majority interest in Baptist Health, the faith-based integrated health system operating across Central Alabama. Upon closing, Orlando Health will become the majority and managing partner of Baptist Health, assuming day-to-day operational management of the system in partnership with Baptist Health System, which retains its minority stake and continues to anchor the organisation's faith-based mission |
| 06/2024 | INTEGRAL DIAGNOSTICS LIMITED | CAPITOL HEALTH LIMITED | AUSTRALIA | Health Providers | Integral Diagnostics acquired 100% of Capitol Health via a Scheme of Arrangement. The transaction was approved by the ACCC after initial concerns, creating a highly synergistic group. The merger consolidates the fragmented Australian radiology market and provides the combined "MergeCo" with significant scale to invest in teleradiology (IDXt) and advanced AI diagnostic technologies |
| 06/2024 | L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENT | PSV GROUP | FRANCE | Health Providers | L-GAM, CAPZA, IDIA Capital Investissement, and Bpifrance are acquiring a minority stake in PSV Group from its associate physicians. The transaction allows for the entry of a consortium of minority financial partners while ensuring that the associate doctors, who remain majority shareholders, retain full operational and strategic control of the group |
| 01/2024 | ARDIAN / BPIFRANCE / MACSF | APRIUM PHARMACIE | FRANCE | Health Providers | Ardian's acquisition of Sagard's majority stake in Healthy Group, the parent company of Aprium Pharmacie, marks the end of a seven-year investment cycle characterized by the institutionalization of the platform and sustained organic growth of over 18% per annum between 2019 and 2023 |
| 12/2023 | ESSLING CAPITAL | X-RAY PHOCEA | FRANCE | Health Providers | X-Ray Phocea, a leading medical imaging group in Southern France, has secured a strategic minority investment from Essling Expansion, alongside Bpifrance and SOFIPACA. Despite this new capital entry, the majority of the group�s shareholding remains in the hands of its 20 associate radiologists, preserving a practitioner-led management model |
| 12/2023 | ANDERA PARTNERS | GROUPE IMAGERIE CARDINET | FRANCE | Health Providers | Andera Acto is providing minority financing to Imagerie Cardinet to support its next phase of expansion. The transaction is structured to allow the associate radiologists to maintain a massive majority, representing approximately 95% of the capital |
REFERENCES
Valuation range: EV 50M - 150M EUR
Revenue range: 10M - 30M EUR
EBITDA range: 5M - 25M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMPC (IMAGERIE MEDICALE PARIS CENTRE) by QUALIUM are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Target: impc (imagerie medicale paris centre)
Acquirer: qualium